Zobrazeno 1 - 10
of 139
pro vyhledávání: '"Sugrue DM"'
Autor:
Pollock KG; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK., Dickerson C; Health Economics and Outcomes Research Ltd, Cardiff, UK., Kainth M; Primrose Lane Health Centre, Wolverhampton, UK., Lawton S; School of Medicine, Keele University, Staffordshire, UK., Hurst M; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK., Sugrue DM; Health Economics and Outcomes Research Ltd, Cardiff, UK., Arden C; University Hospital Southampton, Southampton, UK., Davies DW; London Heart Practice, London, UK., Martin AC; Service de Cardiologie, Université de Paris, Innovative Therapies in Haemostasis, INSERM, Hôpital Européen Georges Pompidou, 20 rue Leblanc, Paris, France., Sandler B; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK., Gordon J; Health Economics and Outcomes Research Ltd, Cardiff, UK. jason.gordon@heor.co.uk., Farooqui U; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK., Clifton D; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, UK., Mallen C; School of Medicine, Keele University, Staffordshire, UK., Rogers J; PHASTAR, London, UK., Hill NR; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK., Camm AJ; Cardiology Clinical Academic Group, Molecular & Clinical Sciences Research Institute, St. George's University of London, London, UK., Cohen AT; Department of Haematological Medicine, Guys and St Thomas' NHS Foundation Trust, King's College London, London, UK.
Publikováno v:
BMC primary care [BMC Prim Care] 2024 Jan 02; Vol. 25 (1), pp. 7. Date of Electronic Publication: 2024 Jan 02.
Autor:
Hill, NR, Groves, L, Dickerson, C, Boyce, R, Lawton, S, Hurst, M, Pollock, KG, Sugrue, DM, Lister, S, Arden, C, Davies, DW, Martin, A-C, Sandler, B, Gordon, J, Farooqui, U, Clifton, D, Mallen, C, Rogers, J, Camm, AJ, Cohen, AT
Objective:The PULsE-AI trial sought to determine the effectiveness of a screening strategy that included a machine learning risk prediction algorithm in conjunction with diagnostic testing for identification of undiagnosed atrial fibrillation (AF) in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::669a219acd708384b8b9e79e7bf73096
Autor:
Hill NR; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK., Groves L; Health Economics and Outcomes Research Ltd, Cardiff, UK., Dickerson C; Health Economics and Outcomes Research Ltd, Cardiff, UK., Ochs A; Health Economics and Outcomes Research Ltd, Cardiff, UK., Pang D; Health Economics and Outcomes Research Ltd, Cardiff, UK., Lawton S; School of Medicine, Keele University, Staffordshire, UK., Hurst M; Health Economics and Outcomes Research Ltd, Cardiff, UK., Pollock KG; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK., Sugrue DM; Health Economics and Outcomes Research Ltd, Cardiff, UK., Tsang C; Health Economics and Outcomes Research Ltd, Cardiff, UK., Arden C; University Hospital Southampton, Southampton, UK., Wyn Davies D; St Mary's Hospital, London, UK., Martin AC; Université de Paris, INSERM, Innovative Therapies in Haemostasis, F-75006 Paris, France.; Service de Cardiologie, AP-HP, Hôpital Européen Georges Pompidou, F-75015 Paris, France., Sandler B; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK., Gordon J; Health Economics and Outcomes Research Ltd, Cardiff, UK., Farooqui U; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK., Clifton D; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, UK., Mallen C; School of Medicine, Keele University, Staffordshire, UK., Rogers J; PHASTAR, London, UK., Camm AJ; Cardiology Clinical Academic Group, Molecular & Clinical Sciences Research Institute, St George's University of London, London, UK., Cohen AT; Department of Haematological Medicine, Guys and St Thomas' NHS Foundation Trust, King's College London, London, UK.
Publikováno v:
European heart journal. Digital health [Eur Heart J Digit Health] 2022 Mar 23; Vol. 3 (2), pp. 195-204. Date of Electronic Publication: 2022 Mar 23 (Print Publication: 2022).
Autor:
Hill NR; Bristol Myers Squibb Pharmaceuticals Ltd., Uxbridge, UK., Groves L; HEOR, Unit A, Health Economics and Outcomes Research Ltd., Cardiff, UK., Dickerson C; HEOR, Unit A, Health Economics and Outcomes Research Ltd., Cardiff, UK., Boyce R; HEOR, Unit A, Health Economics and Outcomes Research Ltd., Cardiff, UK., Lawton S; School of Medicine, Keele University, Staffordshire, UK., Hurst M; Bristol Myers Squibb Pharmaceuticals Ltd., Uxbridge, UK., Pollock KG; Bristol Myers Squibb Pharmaceuticals Ltd., Uxbridge, UK., Sugrue DM; HEOR, Unit A, Health Economics and Outcomes Research Ltd., Cardiff, UK., Lister S; Bristol Myers Squibb Pharmaceuticals Ltd., Uxbridge, UK., Arden C; NHS Foundation Trust, University Hospital Southampton, Southampton, UK., Davies DW; London Heart Practice, London, UK., Martin AC; Université de Paris, Innovative Therapies in Haemostasis, INSERM, Hôpital Européen Georges Pompidou, Service de Cardiologie, Paris, France., Sandler B; Bristol Myers Squibb Pharmaceuticals Ltd., Uxbridge, UK., Gordon J; HEOR, Unit A, Health Economics and Outcomes Research Ltd., Cardiff, UK., Farooqui U; Bristol Myers Squibb Pharmaceuticals Ltd., Uxbridge, UK., Clifton D; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, UK., Mallen C; School of Medicine, Keele University, Staffordshire, UK., Rogers J; Statistical Research and Consultancy, Unit 2, PHASTAR, London, UK., Camm AJ; Cardiology Clinical Academic Group, Molecular & Clinical Sciences Research Institute, St. George's University of London, London, UK., Cohen AT; Department of Haematological Medicine, Guys and St Thomas' NHS Foundation Trust, King's College London, London, UK.
Publikováno v:
Journal of medical economics [J Med Econ] 2022 Jan-Dec; Vol. 25 (1), pp. 974-983.
Autor:
Asker B; GIT Center, Baghdad, Iraq., Jawad R; GIT Center, Baghdad, Iraq., Asreah R; Baghdad Teaching Hospital, Baghdad, Iraq., Jamal H; Sulaimania Hospital, Sulaimania, Iraq., Jassem A; Najaf Hospital, Najaf, Iraq., Inaya MA; Najaf Hospital, Najaf, Iraq., Baker HA; Sulaimania Hospital, Sulaimania, Iraq., Kozma S; Gilead Sciences, Dubai, United Arab Emirates., Mansour E; Gilead Sciences, Dubai, United Arab Emirates., McNamara B; Health Economics and Outcomes Research Ltd, Cardiff, UK., Miller R; Health Economics and Outcomes Research Ltd, Cardiff, UK., Darlington O; Health Economics and Outcomes Research Ltd, Cardiff, UK., McEwan P; Health Economics and Outcomes Research Ltd, Cardiff, UK., Sugrue DM; Health Economics and Outcomes Research Ltd, Cardiff, UK. daniel.sugrue@heor.co.uk., Jarallah H; Basra Hospital, Basra, Iraq.
Publikováno v:
PharmacoEconomics [Pharmacoeconomics] 2021 Nov; Vol. 39 (11), pp. 1327-1341. Date of Electronic Publication: 2021 Aug 16.
Autor:
Krugliak Cleveland, Noa1 (AUTHOR) Noa.Cleveland@uchospitals.edu, Ghosh, Sabyasachi2 (AUTHOR), Chastek, Benjamin3 (AUTHOR), Bancroft, Tim3 (AUTHOR), Candela, Ninfa2 (AUTHOR), Fan, Tao2 (AUTHOR), Umashankar, Kandavadivu2 (AUTHOR), Rubin, David T.1 (AUTHOR)
Publikováno v:
BMC Gastroenterology. 9/17/2024, Vol. 24 Issue 1, p1-12. 12p.
Autor:
Putri, Septiara1,2 (AUTHOR) s.putri.2@research.gla.ac.uk, Ciminata, Giorgio1 (AUTHOR), Lewsey, Jim1 (AUTHOR), Jani, Bhautesh3 (AUTHOR), McMeekin, Nicola1 (AUTHOR), Geue, Claudia1 (AUTHOR)
Publikováno v:
BMC Health Services Research. 9/13/2024, Vol. 24 Issue 1, p1-11. 11p.
Autor:
Hill NR; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK. Electronic address: Nathan.Hill@bms.com., Arden C; Park Surgery, Chandlers Ford, Hampshire, UK. Electronic address: chrisarden@nhs.net., Beresford-Hulme L; Health Economics and Outcomes Research Ltd, Cardiff, UK. Electronic address: l.m.beresford91@googlemail.com., Camm AJ; Cardiology Clinical Academic Group, Molecular & Clinical Sciences Research Institute, St. George's University of London, London, UK. Electronic address: jcamm@sgul.ac.uk., Clifton D; Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, UK. Electronic address: davidc@robots.ox.ac.uk., Davies DW; St Mary's Hospital, London, UK., Farooqui U; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK. Electronic address: Usman.Farooqui@bms.com., Gordon J; Health Economics and Outcomes Research Ltd, Cardiff, UK. Electronic address: jason.gordon@heor.co.uk., Groves L; Health Economics and Outcomes Research Ltd, Cardiff, UK. Electronic address: lara.groves@heor.co.uk., Hurst M; Health Economics and Outcomes Research Ltd, Cardiff, UK. Electronic address: michael.hurst@heor.co.uk., Lawton S; School of Medicine, Keele University, Staffordshire, UK. Electronic address: s.a.lawton@keele.ac.uk., Lister S; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK. Electronic address: Steven.Lister@bms.com., Mallen C; School of Medicine, Keele University, Staffordshire, UK. Electronic address: c.d.mallen@keele.ac.uk., Martin AC; Université de Paris, Innovative Therapies in Haemostasis, INSERM, Hôpital Européen Georges Pompidou, Service de Cardiologie, 20 rue Leblanc, Paris, France., McEwan P; Health Economics and Outcomes Research Ltd, Cardiff, UK. Electronic address: phil.mcewan@heor.co.uk., Pollock KG; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK. Electronic address: Kevin.Pollock@bms.com., Rogers J; PHASTAR, London, UK. Electronic address: jennifer.rogers@phastar.com., Sandler B; Bristol Myers Squibb Pharmaceutical Ltd, Uxbridge, UK. Electronic address: Belinda.Sandler@bms.com., Sugrue DM; Health Economics and Outcomes Research Ltd, Cardiff, UK. Electronic address: daniel.sugrue@heor.co.uk., Cohen AT; Department of Haematological Medicine, Guys and St Thomas' NHS Foundation Trust, King's College London, London, UK. Electronic address: alexander.cohen@kcl.ac.uk.
Publikováno v:
Contemporary clinical trials [Contemp Clin Trials] 2020 Dec; Vol. 99, pp. 106191. Date of Electronic Publication: 2020 Oct 19.
Autor:
Sugrue DM; Health Economics and Outcomes Research Limited, Rhymney House, Unit A Copse Walk, Cardiff Gate Business Park, Cardiff, CF23 8RB, UK. daniel.sugrue@heor.co.uk., Ward T; Health Economics and Outcomes Research Limited, Rhymney House, Unit A Copse Walk, Cardiff Gate Business Park, Cardiff, CF23 8RB, UK., Rai S; Health Economics and Outcomes Research Limited, Rhymney House, Unit A Copse Walk, Cardiff Gate Business Park, Cardiff, CF23 8RB, UK., McEwan P; Health Economics and Outcomes Research Limited, Rhymney House, Unit A Copse Walk, Cardiff Gate Business Park, Cardiff, CF23 8RB, UK., van Haalen HGM; AstraZeneca, Gothenburg, Sweden.
Publikováno v:
PharmacoEconomics [Pharmacoeconomics] 2019 Dec; Vol. 37 (12), pp. 1451-1468.
Autor:
Hill NR; Bristol-Myers Squibb Pharmaceutical Ltd, Uxbridge, United Kingdom., Ayoubkhani D; Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom., McEwan P; Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom., Sugrue DM; Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom., Farooqui U; Bristol-Myers Squibb Pharmaceutical Ltd, Uxbridge, United Kingdom., Lister S; Bristol-Myers Squibb Pharmaceutical Ltd, Uxbridge, United Kingdom., Lumley M; Pfizer Ltd, Surrey, United Kingdom., Bakhai A; Department of Cardiology, Royal Free Hospital, London, United Kingdom., Cohen AT; Department of Haematological Medicine, Guys and St Thomas' NHS Foundation Trust, King's College London, London, United Kingdom., O'Neill M; Division of Cardiovascular Medicine, Guys and St Thomas' NHS Foundation Trust, King's College London, London, United Kingdom., Clifton D; Department of Engineering Science, University of Oxford, Oxford, United Kingdom., Gordon J; Health Economics and Outcomes Research Ltd, Cardiff, United Kingdom.
Publikováno v:
PloS one [PLoS One] 2019 Nov 01; Vol. 14 (11), pp. e0224582. Date of Electronic Publication: 2019 Nov 01 (Print Publication: 2019).